Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 11Other hematologic neoplasm 6Thoracic 1Sarcoma 1Plasma cell 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Sarcoma, Synovial 1Prostatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid 1Glioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Burkitt Lymphoma 1

Interventions

Flow Cytometry 6Cyclophosphamide 6Therapeutics 5Radiotherapy 5fludarabine phosphate 4Polymerase Chain Reaction 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Methylprednisolone 4Carboplatin 4Whole-Body Irradiation 3Thiotepa 3Psychiatric Rehabilitation 3Immunoenzyme Techniques 3Filgrastim 3Cyclosporine 3Caspofungin 3Busulfan 3Antilymphocyte Serum 3thymoglobulin 2liposomal amphotericin B 2alvocidib 2aflibercept 2Voriconazole 2Tacrolimus 2Prednisone 2Ondansetron 2Microarray Analysis 2Methotrexate 2Melphalan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × Immunotherapy, Adoptive × Genitourinary × Clear all
NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Shenzhen BinDeBio Ltd.

Phase 1/2 Unknown
73 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡